Cardiogen
Overview
Research-use synthetic tetrapeptide supplied for studies of cardiomyocyte signaling, cardiac stress-response, and gene-regulation models.
- Concentration
- 20 mg
- Stock
- In stock
Product details
Cardiogen is a synthetic tetrapeptide used as a research tool for cardiac cell-signaling and gene-regulation models. Pattern lists this material for controlled laboratory research.
Research Targets: Cardiomyocyte transcription pathways, mitochondrial stress-response signaling, cardiac cell homeostasis models.
Key Feature: Short bioregulatory peptide format for cardiac pathway research.
Research Focus Areas: Cardiac gene regulation, myocardial stress-response models, cardiomyocyte homeostasis, oxidative-stress pathway studies.
Common Models: Cardiomyocyte culture assays, ischemia-reperfusion model systems, cardiac aging models.
Mechanistic Interests: Transcriptional regulation, mitochondrial integrity markers, apoptosis-associated signaling, cardiac tissue-response pathways.
Use Boundary: Research use only; not for human or veterinary use; no diagnostic, therapeutic, or consumption use is implied.
Research context
Peptide guide
Open full guide- Guide profile
- AEDR Cardiac Bioregulator Peptide
- Composition
- Short synthetic tetrapeptide commonly described as Ala-Glu-Asp-Arg (AEDR) from the Khavinson peptide bioregulator class
- Discovery
- Associated with Russian peptide bioregulator research led by Khavinson and colleagues, where short peptides were studied for organ- and tissue-specific regulatory effects
- Research scope
- Published evidence is limited compared with mainstream cardiovascular drugs; much of the Cardiogen-specific literature is preclinical, regional, or derived from broader short-peptide bioregulator work
- Regulatory status
- Research-only with limited high-quality human evidence
Safety context
- Acute or unstable cardiovascular disease without medical care
- Pregnancy or breastfeeding
- Known hypersensitivity
Research-use notice: Cardiogen is a research bioregulator peptide, not an approved cardiovascular treatment. Evidence is preliminary and should not replace guideline-directed medical care, emergency evaluation, or prescribed cardiovascular therapy.
Full guide includes 10 reference entries.
One kit adds 10 vials to checkout.